. All receive extracts from all deaths certificates for residents of their region which mention cancer.
The England and Wales data set of over 5 million cancer registrations is exceptionally large, but its use to examine secular and cohort trends in cancer incidence and to provide incidence data in cohort studies, has been hampered by uncertainty about the degree of completeness of registration. A study by Villard-Mackintosh et al. (1988) of cancers in women reported to the Oxford-FPA contraceptive study, suggested about 89% eventual completeness of registration at national level in England for cancers incident 1968-83, but based on very uneven representation of regional registries and small numbers from many of them. Data for children suggest 95% completeness of regional registration overall in England and Wales 1971-84, with 3% of these registrations failing to reach the national register (Hawkins & Swerdlow, in press ). These studies were based on comparison between registry data and independently identified lists of cases. Such a study has also been published for one regional registry (Nwene & Smith, 1982) (Swerdlow, 1986 region, for which we did not have data, had the mean failure rate of the rest of the country. The overall result was robust to variation in this assumption, however: halving or doubling the estimate for North Western region altered the national total by under 0.4% (to 3.0 and 3.4% respectively).
Discussion
The study is based on a far larger sample of malignancies at adult ages than any previously, but certain methodological points need to be noted in interpretation.
It is problematic whether registrations with erroneous diagnostic codes should be counted as valid when assessing completeness of registration. We included non-Hodgkin's lymphoma and unspecified lymphoma diagnoses as valid in the present estimates, because the diagnoses in the BNLI are those verified by the BNLI pathology panel, which may differ from the exact lymphoma diagnoses available locally to regional cancer registries. We did not include non-lymphoma registrations as valid, but since these were 0.1% of the total their inclusion would have made a negligible difference.
Use of the National Health Service Central Register was the only way by which we could search for registrations in the national files recorded with a different site, or with an incidence year substantially discrepant, from that recorded by the BNLI. (Checks with the regional registries ascertained these cases for the regional registers but could not determine whether the information had then reached the national register.) Use of the NHSCR may have led to marginal under-estimation of national (but not regional) completeness, since recorded of nationally registered cancers in the NHSCR is somewhat incomplete (see below). The effect of this should have been small, however, since few registrations are likely to have been this discrepant in recording of incidence year (certainly few were found regionally to be substantially discrepant), and most of these should have been in the NHSCR.
Most of the BNLI cases for whom no cancer registration could be found were in persons traced on the NHSCR, and hence they should have been eligible for inclusion in the registration system. The small number of BNLI cases not traced at NHSCR might have included malignancies in foreign visitors, which are not within the scope of the England and Wales registration scheme. Judging from the names of the untraced patients and their length of follow up in Britain by the BNLI, however, such instances were few if any. Only four of the unregistered cases were lost to follow up by emigration.
The study was only of one malignancy, Hodgkin's disease, which might not be representative of cancers overall. In a study of completeness of registration of many different cancers in North Western region, however, Nwene and Smith (1982) found completeness for Hodgkin's disease close to that for cancers overall. Nevertheless, because of the restriction to one malignancy caution is needed in extrapolation of the results to cancer registration generally.
Caution is also needed in interpretation because, like several previous studies comparing cancer registries with an independent source, the independently identified cases are a selected sample of all cases in the country, although not one obviously biased with respect to cancer registration at a national level. The BNLI includes several major centres and many smaller ones treating lymphomas in Britain, with a wide geographic spread. Usually, all of the consultants at a participating centre are members, but this is not invariably the case. Many centres have been members throughout the study period, but some have left or entered during it. The patients included in the completeness analyses are those in the BNLI's 'study files', whom the BNLI members have entered into controlled trials or other clinical studies, and for whom as a result the BNLI central office hold complete and detailed information. These patients are the majority of all patients treated by the BNLI members, but omitting young children and probably including only a minority of the most elderly patients. On a national scale there is no obvious reason why the centres included in the BNLI should be better or worse in relation to cancer registration than other centres in the country -cancer registration in England and Wales is not carried out by the consultants personally, but by clerical officers, inspection of national death certificates, use of computerised hospital record systems, etc (see Swerdlow, 1986) . At a regional level there is a greater risk that the particular centres within the BNLI might by chance be atypical ones with regard to registration, and this seems particularly a potential problem in the Thames regions where certain major treatment centres are members of the BNLI and others are not. This may explain why the findings on completeness by region, although mainly in line with those one would expect from other sources (see Swerdlow, 1986) , appear better than might be expected for the North Thames regions. With regard to analyses of completeness of registration over time, the fact that some centres have entered BNLI and others left during the study period means that the results for the early and late parts of the study period are not based on exactly the same centres, although the centres entering and leaving are not obviously ones which would introduce a bias for or against better registration. Our expectation from other sources would have been of a small improvement in registration completeness nationally over the study period, and it is possible that the lack of such an effect in the data may reflect small changes in the membership of the BNLI during the period.
The study was solely of cases diagnosed or treated at hospitals. Registration completeness for such cases might differ from that for cases never seen in hospital. The effect of this should be negligible for Hodgkin's disease, for which extremely few cases in the country would fail to receive any hospital diagnosis or treatment. The effect should also be reasonally small for most other cancers, with the exception of non-melanoma skin cancer and cancers in the very elderly. The study included some but not all of the private patients (who might be worse registered) treated by BNLI consultants during the period. Again, however, the effect on the study results should be small, since private patients are a very small proportion of all Hodgkin's disease patients. The effect of private patients may be a little larger for certain other malignancies.
The BNLI has continued to enroll patients since 1984, but we did not include these in the present study because it takes several years for the national registry to reach its eventual level of completeness. Few further registrations for years before 1985 can now be expected to be entered in the regional and national registration schemes (Hawkins & Swerdlow, in press ), but to the extent that they do occur the present completeness estimates may be marginally too low. Eventual completeness needs as far as possible to be separated analytically from delays in registration, since the extent of the temporary incompleteness from the latter depends entirely on the date at which it is assessed. Studies which do not separate these two elements are difficult to interpret. It should also be noted that the present data relate only to completeness of regional and national cancer registers, not to the notification of cancers to research workers by the National Health Service Central Register (NHSCR). Several studies indicate that this notification is appreciably less complete than the cancer registers (Hunt & Coleman, 1987; Villard-Mackintosh et al., 1988; Darby et al., 1988; Hawkins & Swerdlow, in press), because not all registered cancers reach the NHSCR, and not all cancers recorded at NHSCR are correctly notified.
Despite the reservations discussed above, the present results fit with most other available evidence on cancer registration completeness (after allowance for lag periods). A study of cancers incident in women of childbearing age and reported to the Oxford-FPA contraceptive study included 267 cases, incident 1968-83, for whom at least 41 years had elapsed since incidence. For these, there was 89% completeness of registration by the registries in England by the end of the study period (Villard-Mackintosh et al., 1988), (There was lower completeness by the study end-date for cancers incident 1984-85, for which fewer years had yet elapsed). A study of 50 independently identified breast cancers, mainly from London, implied 92% eventual completeness at regional level (Hunt & Coleman, 1987 ). An analysis based on the national childhood register suggests 95% completeness of registration at regional level and 92% at national level for cancers in children 1971-84 (Hawkins & Swerdlow, in press) . Registration is likely to be easier, and completeness greater, in children than in adults, however. Ninety five per cent or greater completeness has been suggested for certain regional registries (Nwene & Smith, 1982; Trout, 1982; Waterhouse, 1987) , but in only one instance (Nwene & Smith, 1982) was a comparison to an independent registration source presented. Indirect evidence from mortality to registration ratios suggests considerable regional variation in completeness (Swerdlow, 1986 ), but does not enable quantification of this. The differences, however, are in general in the same directions as the data presented here.
Thus in summary, the present data and consideration of previous smaller studies and indirect evidence suggest that during the period 1971-84 England and Wales cancer registration was about or slightly over 90% complete at regional level, that about 3% of the registrations then failed to reach the national registry, and that there was considerable regional variation in completeness, with figures in several regions of 95% or better.
